Frontlight ResearchEarly access
Trial site
Beirut
- 7running trials
- 8closed trials
The trials here
What the 15 trials at this site are about, from their registry records.
- Conditions
- Chronic myeloid leukaemia4 trials
- Childhood cancers3 trials
- Multiple sclerosis3 trials
- Sickle cell disease3 trials
- Myeloproliferative neoplasms2 trials
- Acute lymphoblastic leukaemia1 trial
- Acute myeloid leukaemia1 trial
- Familial hypercholesterolaemia1 trial
- Heart failure1 trial
- Lung cancer1 trial
- Metastatic breast cancer1 trial
- Myelodysplastic syndromes1 trial
- and 2 more
- Phase
- Phase 38 trials
- Phase 45 trials
- Phase 21 trial
- Status
- Completed7 trials
- Active, not recruiting6 trials
- Recruiting1 trial
- Terminated1 trial
- Lead sponsor
- Novartis Pharmaceuticals15 trials
Running trials
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Sickle cell disease1 recruiting
Closed trials
Completed
Recruiting
Completed
Terminated
Completed
Completed
Study of Dose Confirmation and Safety of Crizanlizumab in Pediatric Sickle Cell Disease Patients
Completed
Completed
Site data: ClinicalTrials.govUpdated 15 Nov 2026